Synthesis of 5-(7-Hydroxyheptyl)-1,2-dithiolan-3-one 1-Oxide,a Core Functionality of Antibiotic Leinamycin

5-(7-Hydroxyheptyl)-1,2-dithiolan-3-one 1-oxide was designed and synthesized in our laboratories that contain the heterocycle of 1,2-dithiolan-3-one 1-oxide, a reactive core of antibiotic leinamycin. In addition, the activated ester of 5-(7-hydroxyheptyl)-1,2-dithiolan-3-one 1-oxide was prepared, which presumably is useful for coupling this DNA-cleaving functionality to certain DNA-binding agents.     

Influence of Nucleation Agents Concentration on Crystallization Structure and Properties of Glass-ceramics

Deep color glass-ceramics is prepared by using gold tailings as the main raw material, and Cr2O3 is added as nucleation agent. Influence of different Cr2O3 additions on crystallization structure and properties of CaO-MgO-Al2O3-SiO2 glass-ceramics has been discussed so as to select optimum additions. DTA is employed to determine optimum crystallization and nucleation temperatures; XRD and SEM are used to characterize microstructure of each sample; and performance indexes, such as water absorption, bulk density, flexural strength and so on, are also determined. Experimental results show that when 3wt% Cr2O3 is introduced, fine glass-ceramics with diopside as the main crystal and Ca-Fe diopside as the second-crystal is obtained, and its corresponding performance indexes are as follows: water absorption 0.12%, bulk density 2.56 g/cm3, and flexural strength 70.01 Mpa.     

化学战剂的SERS检测及应用前景研究

化学武器和技术的扩散使化学恐怖活动成为事关世界安全的突出问题之一.针对化学战剂的高毒性和快速致命特点,表面增强拉曼散射(SERS)光谱技术研究可以实现生化战剂的快速、高灵敏实时检测,有助于战时和突发恐怖袭击时对人员的及时救治和预防,为更好的防范化学武器威胁和恐怖袭击提供必要的技术保障.本文主要对SERS技术在化学战剂检...     

Efficient method to prepare diethylphosphonacetamides

An efficient and versatile synthetic method is described to synthesize diethylphosphonacetamides in a single step.     

The Cu- and Zn-complex-catalyzed methanolysis of the chemical warfare nerve agents soman,sarin, and VX

The catalytic methanolysis of the chemical warfare nerve agents soman, sarin, and VX was investigated by using Cu or Zn complexes. Although VX withstood decontamination, the decomposition yield being around 96%, the soman and sarin deposited on different surfaces were almost fully destroyed under ambient conditions. The catalytic tests performed on a wide range of contaminated surfaces confirm the activity of the investigated catalytic systems, these complexes being suitable, from an economical point of view, for use in the formulation of a possible decomposition kit with military or civilian applicability.     

Targeting bacterial toxins

Protein toxins constitute the main virulence factors of several species of bacteria and have proven to be attractive targets for drug development. Lead candidates that target bacterial toxins range from small molecules to polymeric binders, and act at each of the multiple steps in the process of toxin-mediated pathogenicity. Despite recent and significant advances in the field, a rationally designed drug that targets toxins has yet to reach the market. This Review presents the state of the art in bacterial toxin targeted drug development with a critical consideration of achieved breakthroughs and withstanding challenges. The discussion focuses on A-B-type protein toxins secreted by four species of bacteria, namely Clostridium difficile (toxins A and B), Vibrio cholerae (cholera toxin), enterohemorrhagic Escherichia coli (Shiga toxin), and Bacillus anthracis (anthrax toxin), which are the causative agents of diseases for which treatments need to be improved.     

A Convenient Preparation of 2-(2-Arylidene)- and 2-(2-Polyhydroxyalkylidene)hydrazono-4-imidazolidinones with Various Heterocyclic Side Chain Substituents at Position 5 as Potential Antiviral and Antitumor Agents

A variety of novel 5-[( Z )-arylidene]-2-[(2-( E )-arylidene)hydrazono]-4-imidazolidinones 1a-c to 4a , b and 5-[( Z )-arylidene]-2-[(2-( E )-polyhydroxyalkylidene)hydrazono]-4-imidazolidinones 5a-c to 7a-c were prepared from the reaction of 5-[( Z )-arylidene]-2-methylmercaptohydantoins 8a-c with 2-( E )-arylidene hydrazones 13a-d and/or 2-( E )-monosaccharides hydrazones 16a-c . The linear structure, and not that of the angular isomer, has been selected for the products. This structure has been confirmed from a model study of the condensation of 5-[( Z )-2-thienylidene]-2-hydrazono-4-imidazolidinone 9a with benzaldehyde and D -galactose, respectively. The acetylation and benzoylation reactions of compounds 1-7 have been studied. All the new compounds were tested for their potential antiviral and antitumor activities.     

Effect of Some Precipitating and Complexing Agents on the Potential of an Ion-Selective Pb(II) - Electrode

Abstract

The influence of some precipitating and complexing agents on the function of Pb(II)-sensitive electrode was studied. On the basis of the experimental findings, procedures were worked out for determining oxalate, phosphate, chromate, nitrilotriacetic acid (NTA), sodium diethyldithiocarbamate (NaDDC), and diethylenetetraamine penta-acetic acid (DTPA) with a standard Pb(II) solution as a titrant and a Pb(II), -sensitive electrode as a detector. The reverse titration of Pb(II), with any of these agents could also be done.     

Crystal and molecular structures of benzophenone phenylhydrazone derivatives with anticancer activity

The X-ray crystal structures of 4,4-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (I) and 2,2-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (II) have been determined in order to study the structural characteristics of these molecules that may contribute to their antiestrogenic and cytotoxic properties. These structures have been compared to other hydrazone derivatives as well as tamoxifen, an antiestrogen drug presently used clinically for the treatment of breast cancer.Crystal data: (I) C₁₉H₁₄N₄O₆ · C₄H₁₀O; MW=468.0; monoclinic,P2₁;a=8.601(2), b=15.502(8), c=16.851(4) Å,=98.58(2)°;Z=8; finalR=0.036 for 1904 observed reflections. (II C₁₉H₁₄N₄O₆ · H₂O; MW=410.0; monoclinic,P2₁/c;a=7.603(2),b=19.552(4),c=12.493(3) Å,=92.11(1)°;Z=4; finalR=0.045 for 1171 observed reflections.     

Analgesic Buxus alkaloids with Enhanced Selectivity for the Low-Voltage-Gated Calcium Channel Cav3.2 over Cav3.1 through a New Binding Mode

Low-voltage-gated calcium channels (LVGCCs; Ca_v3.1-3.3) represent promising drug targets for epilepsy, pain, and essential tremor. At present, modulators with heightened selectivity for a subtype of LVGCCs are still highly desired. In this study we explored three classes of Buxus alkaloids and identified 9(10/19)abeo-artanes Buxusemine H and Buxusemine L (BXSL) as an unprecedented type of Ca_v3.2 inhibitors. Particularly, BXSL exhibited Ca_v3.2 inhibition comparable to Z944, a non-subtype-selective LVGCCs inhibitor under clinical trial. While lacking specificity for Ca_v3.3, BXSL showed a 30-fold selectivity of Ca_v3.2 over Ca_v3.1. As compared to several well-known inhibitors, the experimental and computational studies suggested BXSL exhibits a distinct binding mode to Ca_v3.2, notably through the essential interaction with serine-1543 in domain III. Furthermore, BXSL showed minimal impact on various recombinant and native nociceptive ion channels, while significantly reducing the excitability of isolated mouse dorsal root ganglion neurons. Animal studies in wild-type and Ca_v3.2 knock-out mice revealed that BXSL (5 mg/kg), by inhibiting Ca_v3.2, exhibits an analgesic effect equivalent to Z944 (10 mg/kg) or mibefradil (10 mg/kg). Moreover, we proposed a structural rationale for the high selectivity of 9(10/19)abeo-artane-type alkaloids towards Ca_v3.2 over Ca_v3.1. This study introduces a novel analgesic agent and valuable molecular insight for structure-based innovative Ca_v3.2 drug development.